ITI News Archive
Stanford Medicine News
Altered immune cells attack brain tumor
In mice, a fatal brainstem tumor was cleared by injecting it with engineered T cells that recognized the cancer and targeted it for destruction. The Stanford discovery is moving to human trials.
Tough transplant cases? Hospital up to the task
Dane Conrads, now almost 4, was “desperately ill” when he received his liver transplant in 2014. Last year, he also benefited from one of the most complicated kidney transplants ever performed at Packard Children’s Hospital.
Conference on human immune monitoring
The two-day event will highlight the latest research by top scientists on technologies and analytic methods geared toward studying human immunology.
Antibody treatment for ‘bubble boy’ disease
In a clinical trial, participants were given an antibody to CD117, a cell surface marker, in an effort to wipe out their defective blood stem cells without high-risk chemotherapy or radiation.
Iron triggers lung transplant infection
Iron enables a common mold to take root in lung transplant recipients, according to Stanford researchers who led a study that offers a new perspective for understanding and treating these pulmonary infections.
Schneider on disease and data sculptures
Many infectious diseases, including malaria, are marked by cyclical ups and downs. David Schneider takes a creative approach to making sense of those ups and downs.
'Vaccine’ destroys tumors in mice
Activating T cells in tumors eliminated even distant metastases in mice, Stanford researchers found. Lymphoma patients are being recruited to test the technique in a clinical trial.
50th-anniversary celebration of heart transplant
The landmark heart transplant performed at Stanford in 1968 ultimately led to the success of the operation around the world today.
Landmark heart surgery changed history
On Jan. 6, 1968, as Stanford surgeon Norman Shumway performed the first U.S. adult heart transplantation, the world held its breath.
Screen could reveal immunotherapy targets
Stanford scientists have developed a biochemical screen that identifies molecules critical to immunotherapy for a host of diseases, including cancer.